FEAM Conference 2018

SAMW » Projekte » Personalisierte Gesundheit » FEAM Conference 2018

Precision Medicine and Personalized Health

28. September 2018 | Campus Biotech, Genf

 

Nach dem Erfolg der FEAM Conference 2016 fand am 28. September 2018 die zweite Konferenz der Federation of European Academies of Medicine (FEAM) in der Schweiz statt. Gegen 200 Teilnehmer/innen aus 28 Ländern waren der Einladung von FEAM und SAMW gefolgt, um in Genf jüngste Entwicklungen zum Thema «Precision Medicine and Personalized Health» zu diskutieren. Als Tagungspartner begleitete SantéPerSo die Veranstaltung.

 

Nationale und internationale Expertinnen und Experten beleuchteten das Gebiet der Personalisierten Gesundheit aus verschiedenen Blickwinkeln: Forschungsstand und klinische Anwendungen, nationale und internationale Netzwerke waren genauso im Fokus wie ethische, gesellschaftliche und rechtliche Rahmenbedingungen.

 

Im Vorfeld der FEAM Conference fanden auf dem Campus Biotech in Genf zwei thematisch verwandte Veranstaltungen statt: die 4-tägige ESPT Summer School zum Thema «Precision Medicine & Personalised Health» für achtzig junge Forschende aus ganz Europa, gemeinsam organisiert von der European Society of Pharmaco­genomics and Personalised Therapy (ESPT) und vom Swiss Personalized Health Network (SPHN). Zudem führte das FEAM European Biomedical Policy Forum einen runden Tisch zu «Precision Medicine and Personalized Health» durch.

 

 

Programm und Präsentationen

Programme FEAM Conference 2018

 

Prof. Ron H. N. van Schaik,
European Society of Pharmacogenomics and Personalised Therapy (ESPT) President

Report from the ESPT/SPHN Summer School

 

Prof. Peter J. Meier-Abt, Swiss Personalized Health Network (SPHN) President

Report from the FEAM Forum Round Table

 

Denis Horgan, European Alliance for Personalised Medicine, Brussels, BE

The European Alliance for Personalised Medicine (EAPM) Engages
for Better Health Care Systems in Europe

 

Prof. Tim Hubbard, Genomics England and Department of Medical and Molecular Genetics,
King's College, London, UK

From the 100,000 Genomes Project to the UK NHS Genome Medicine Service

 

Prof. Jaak Vilo, Institute of Computer Science, University of Tartu, EE

Effective Personalized Medicine Requires Highly Integrated Data Infrastructures:
the Example of Estonia

 

Prof. Nan Shen, Ren ji Hospital, Shanghai Jiao Tong University School of Medicine, CN

The Path to Precision Medicine:
Lessons from Applying Personalized Immunology for Managing Autoimmune Diseases in China

 

Prof. Stylianos Antonarakis, Department of Genetic Medicine and Development, University of Geneva, CH

Genomics and Big Data: from Science to Health Care and back

 

Prof. Younglun Luo, Department of Biomedicine, Aarhus University, DK
and Lars Bolund Institute of Regenerative Medicine, BGI-Qingdao, CN

Towards Personalized Regenerative Cell Therapy

 

Prof. Christophe Le Touneau, Department of Drug Development and Innovation, Curie Institute, Paris, FR

Clinical Utility of Precision Medicine in Oncology

 

Prof. Amalio Telenti, The Scripps Research Institute, La Jolla, US

Human Metabolome as an Approach to Personalized Medicine

 

Prof. Jan Albert Kuivenhoven, Department of Pediatrics, University Medical Center Groningen, NL

From Rare to Common Disease: from Genetics to Therapy

 

Prof. Dan M. Roden, Vanderbilt University Medical Center, Nashville, US

Implementation of Pharmacogenomics in Clinical Medicine in the US

 

Prof. Maja Krajinovic, CHU-Sainte-Justine, Montreal, CA

Pharmacogenomics in Pediatric Hemato-Oncology

 

Prof. Munir Pirmohamed, Institute of Translational Medicine, University of Liverpool, UK

Pharmacogenomics of Adverse Drug Reactions

 

Dr. Thorsten Gutjahr, Companion Diagnostics, AstraZeneca, Cambridge, UK

Precision Medicine and Genomics: a Pharma Perspective

 

Prof. Marc Van den Bulcke, Sciensano, Brussels, BE

Perspectives for Public Health Genomics within a Health Care System Context

 

Prof. Ernst Hafen, Institute of Molecular Systems Biology, ETH Zurich, CH

Data to the People: MIDATA Cooperatives

 

Prof. Joshua Hordern, Faculty of Theology and Religion, University of Oxford, UK

Ethical Imperatives for Personalized Medicine

 

 

 

KONTAKT

Dr. Myriam Tapernoux
Ressortleitung